ACTIVE

FINANCIA PHARMA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

171,6 k €

+10.5% YoY

Gross margin

234,9 k €

+9.1% YoY

Equity

1,7 M €

+10.9% YoY

What does FINANCIA PHARMA do?

FINANCIA PHARMA is a Private limited company incorporated in 2010. Its main activity is: Management consultancy activities. Its registered office is in Perwez.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0832.300.679

Incorporation

29/12/2010

Legal form

Private limited company

Registered office

Rue de la Chapelle 35
1360 Perwez · WallonieSee on map

Contributed capital

18 600,00 €

Latest accounts

31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 70210Public relations and communication activities 73300Advertising and market research

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 14 financial years

	2025		2024		2023		2022		2021		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Gross margin	234,9 k €	+9.1%	215,4 k €	+1.9%	211,5 k €	+4.3%	202,7 k €	-5.0%	213,4 k €	+15.1%	185,3 k €	+18.2%	156,8 k €	-0.3%	157,2 k €	+29.4%	121,5 k €	-10.1%	135,1 k €	+47.0%	91,9 k €	-10.3%	102,5 k €	-11.9%	116,3 k €	-0.1%	116,5 k €
EBITDA	233,9 k €	+9.1%	214,5 k €	+1.9%	210,5 k €	+4.3%	201,9 k €	-5.0%	212,5 k €	+14.6%	185,3 k €	+18.8%	156 k €	-0.7%	157,2 k €	+29.4%	121,5 k €	-10.1%	135,1 k €	+47.0%	91,9 k €	-10.3%	102,5 k €	-11.9%	116,3 k €	-0.1%	116,5 k €
Operating result	233,4 k €	+9.1%	214 k €	+1.7%	210,3 k €	+4.2%	201,9 k €	-5.0%	212,5 k €	+14.6%	185,3 k €	+18.8%	156 k €	-0.7%	157,2 k €	+29.4%	121,5 k €	-10.1%	135,1 k €	+59.4%	84,8 k €	-9.4%	93,5 k €	-11.0%	105,1 k €	+3.1%	101,9 k €
Net result	171,6 k €	+10.5%	155,2 k €	+3.6%	149,9 k €	+4.9%	142,9 k €	-6.4%	152,6 k €	+51.8%	100,5 k €	-52.6%	212 k €	+134%	90,5 k €	+40.5%	64,4 k €	+13.3%	56,9 k €	-67.4%	174,2 k €	+265%	47,7 k €	-5.4%	50,5 k €	-5.5%	53,4 k €
Balance sheet
Equity	1,7 M €	+10.9%	1,6 M €	+11.0%	1,4 M €	+11.9%	1,3 M €	+12.7%	1,1 M €	+39.6%	803,6 k €	+14.3%	703,1 k €	+43.2%	491,1 k €	-3.1%	507,1 k €	+14.5%	442,7 k €	+14.7%	385,8 k €	+69.3%	227,9 k €	+16.0%	196,4 k €	+21.1%	162,1 k €
Total assets	2,8 M €	+3.7%	2,7 M €	-9.0%	3 M €	+7.3%	2,8 M €	+3.4%	2,7 M €	+3.4%	2,6 M €	-0.4%	2,6 M €	+118%	1,2 M €	-2.8%	1,2 M €	+2.3%	1,2 M €	-13.7%	1,4 M €	+13.1%	1,2 M €	-1.5%	1,3 M €	-23.5%	1,6 M €
Cash	7,4 k €	+63.8%	4,5 k €	-60.5%	11,5 k €	+60.5%	7,1 k €	-64.5%	20,1 k €	+73.1%	11,6 k €	+513%	1,9 k €	-46.9%	3,6 k €	-60.1%	8,9 k €	-21.9%	11,4 k €	-50.5%	23,1 k €	+382%	4,8 k €	-66.3%	14,2 k €	-20.2%	17,8 k €
Debts	1,1 M €	-7.0%	1,1 M €	-27.0%	1,6 M €	+3.6%	1,5 M €	-3.3%	1,6 M €	-12.7%	1,8 M €	-5.8%	1,9 M €	+171%	705,8 k €	-2.5%	724,2 k €	-4.9%	761,9 k €	-24.5%	1 M €	+0.3%	1 M €	-4.7%	1,1 M €	-28.4%	1,5 M €

Estimate

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Pierre ANCIA

Director

Active

Ended mandates

Pierre ANCIA

Director · since 29 décembre 2010

Ended

PIERRE ANCIA

Manager · since 29 décembre 2010

Ended

PIERRE ANCIA

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
LOUVIMAR● Active	0463.466.493
PHARMACIE DE LA CHAPELLE● Active	0453.011.081
Pharmacie de la Linière● Active	0846.065.375

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	08/07/2026	29/08/2025	31/07/2024	09/10/2023	30/08/2022	16/09/2021
General meeting	08/05/2026	09/05/2025	10/05/2024	23/08/2023	13/05/2022	14/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	08/05/2026	08/07/2026	French	PDF
Micro model	31/12/2024	09/05/2025	29/08/2025	French	PDF
Micro model	31/12/2023	10/05/2024	31/07/2024	French	PDF
Micro modelCorrection	31/12/2022	23/08/2023	09/10/2023	French	PDF
Micro model	31/12/2022	23/08/2023	31/08/2023	French	PDF
Micro model	31/12/2021	13/05/2022	30/08/2022	French	PDF
Micro model	31/12/2020	14/05/2021	16/09/2021	French	PDF
Abridged model	31/12/2019	08/05/2020	21/08/2020	French	PDF
Abridged model	31/12/2018	10/05/2019	20/08/2019	French	PDF
Abridged model	31/12/2017	11/05/2018	23/08/2018	French	PDF
Abridged model	31/12/2016	12/05/2017	03/08/2017	French	PDF
Abridged model	31/12/2015	13/05/2016	25/08/2016	French	PDF
Abridged model	31/12/2014	08/05/2015	06/08/2015	French	PDF
Abridged model	31/12/2013	09/05/2014	19/08/2014	French	PDF
Abridged model	31/12/2012	10/05/2013	30/08/2013	French	PDF
Abridged model	31/12/2011	11/05/2012	30/08/2012	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 3 ended

Active mandates

Pierre ANCIA

Director

Active

Ended mandates

Pierre ANCIA

Director · since 29 décembre 2010

Ended

PIERRE ANCIA

Manager · since 29 décembre 2010

Ended

PIERRE ANCIA

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates09/02/2024
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates21/02/2020
DEMISSIONS, NOMINATIONS
PDF
Capital / shares30/01/2018
CAPITAL, ACTIONS
PDF
Capital / shares04/05/2012
CAPITAL, ACTIONS
PDF
Other31/12/2010
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025171,6 k €↑
2024
Annual accounts 2024155,2 k €↑
2023
Annual accounts 2023149,9 k €↑
2022
Annual accounts 2022142,9 k €↓
2021
Annual accounts 2021152,6 k €↑
2019
Annual accounts 2019100,5 k €↓
2018
Annual accounts 2018212 k €↑
2017
Annual accounts 201790,5 k €↑
2016
Annual accounts 201664,4 k €↑
2015
Annual accounts 201556,9 k €↓
2014
Annual accounts 2014174,2 k €↑
2013
Annual accounts 201347,7 k €↓
2012
Annual accounts 201250,5 k €↓
2011
Annual accounts 201153,4 k €
29/12/2010
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

FINANCIA PHARMA

Overview

What does FINANCIA PHARMA do?

Trend over 14 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline